Fingolimod hcl. 25 mg in patients with relapsing-remitting ...
Fingolimod hcl. 25 mg in patients with relapsing-remitting MS (RRMS) NDC 0078-0965-89 - GILENYA® (fingolimod) capsules - 0. 33 nM。 靶点 体外研究 S1P 作用于K562细胞，抑制NK细胞裂解。 多种浓度 FTY720可逆转S1P的抑制作用，IC50为173 nM。此外, 10 nM FTY720 单独温育时，对共刺激分子的表达没有任何影响。 Find drug information for Gilenya on CVS. It works by targeting a type of immune cell called lymphocytes, reducing the frequency of multiple sclerosis relapses. Slow heart rate (bradycardia or bradyarrhythmia) when you start taking GILENYA. GILENYA can cause your heart rate to slow down, especially after you take your first dose. 25 mg - Equivalent to 0. Provides access to the latest drug monographs submitted to the Food and Drug Administration (FDA). Fingolimod, sold under the brand name Gilenya, is an immunomodulating medication, used for the treatment of multiple sclerosis. 生物活性 Fingolimod (FTY720) HCl是一种S1P拮抗剂，在K562 和 NK细胞中IC50为0. 5 mg and 1. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives. Here we provide some key information on Fingolimod. If covered through the prior authorization process, these drugs will be limited to being dispensed to defined specialty Fingolimod Hydrochloride is the hydrochloride salt form of fingolimod, an orally available derivate of myriocin and sphingosine-1-phosphate receptor 1 (S1PR1, S1P1) modulator, with potential anti-inflammatory and immunomodulating activities. Fingolimod is an oral medication used for the treatment of relapsing remitting MS. Gilenya 0. Nov 4, 2024 · Fingolimod capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary What is this medication? FINGOLIMOD (fin GOL i mod) treats multiple sclerosis (MS). 5 mg of fingolimod) as the active ingredient. National Library of Medicine, DailyMed Database. Fingolimod Hydrochloride, a pharmaceutical secondary standard & certified reference material for use in pharma release testing and pharmaceutical research. Click here for full Prescribing Information. It works by slowing down an overactive immune system, which prevents or delays worsening symptoms. 3 Fingolimod is a sphingosine 1-phosphate receptor modulator for the treatment of relapsing-remitting multiple sclerosis. Please review the latest applicable package insert for additional information and possible updates. 4)]. Name Fingolimod hydrochloride Drug Entry Fingolimod Multiple sclerosis, or MS, is a devastating inflammatory disease that often progresses and causes severe neurological, physical, and cognitive effects. The identity and quality of the drug substance is assured through appropriate in-process controls and adequate final drug substance specification. It is metabolised to its active form, fingolimod phosphate. Dec 20, 2024 · Overview: Fingolimod (Gilenya) is used to treat multiple sclerosis. 0% and NMT 102. When restarting GILENYA after discontinuation for more than 14 days after the first month of treatment, perform first-dose monitoring, because effects on heart rate and AV conduction may recur on reintroduction of GILENYA treatment [see Dosage and Administration (2. Synonym (s): FTY720, 2-Amino-2- [2- (4-octyl-phenyl)-ethyl]-propane-1,3-diol hydrochloride, Fingolimod hydrochloride Empirical Formula (Hill Notation): C19H33NO2 · HCl CareOregon (Medicaid) Specialty Drug List This list reflects medications designated as specialty drugs under the pharmacy benefit. A local search option of this data can be found here. The capsule also contains the following inactive ingredients: Polacrilin potassium Crospovidone Colloidal anhydrous silica Magnesium stearate Fingolimod Sun does not contain gluten, tartrazine or any other azo Interactions, warnings, dosage and more for FINGOLIMOD- fingolimod hcl capsule Fingolimod Adult Medication This information from Lexicomp ® explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to call your healthcare provider. The structural elucidation data support the proposed structure of fingolimod hydrochloride. Most specialty drugs require a prior authorization for medical necessity. 56 mg of fingolimod hydrochloride (equivalent to 0. DEFINITION Fingolimod Hydrochloride contains NLT 98. NDC 0078-0965-89 - GILENYA® (fingolimod) capsules - 0. . com, including related drug classes, side effects, dosage, and answers to frequently asked questions. If covered through the prior authorization process, these drugs will be limited to being dispensed to defined specialty CareOregon (Medicaid) Specialty Drug List This list reflects medications designated as specialty drugs under the pharmacy benefit. Fingolimod (marketed as Gilenya) Information An oral medication for the treatment of relapsing forms of Multiple Sclerosis (MS) in adults. Learn about fingolimod: What is it used for, what you need to know before taking, important warnings and safety info, how to take, side effects and more Fingolimod | C19H33NO2 | CID 107970 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more. Jan 19, 2026 · Fingolimod is used in adults and children at least 10 years old to treat relapsing forms of multiple sclerosis (including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease). Fingolimod hydrochloride (CAS 162359-56-0) information, including chemical properties, structure, melting point, boiling point, density, formula, molecular weight Learn about fingolimod (Gilenya) usage and dosing. The drug substance specification includes tests and acceptance criteria for description, particle size distribution, color and clarity of solution, identity What is the most important information I should know about GILENYA? GILENYA may cause serious side effects, including: 1. 5 mg capsules help manage immune response effectively. Pack of 28 capsules suitable for prescribed immunosuppressant treatment. Each Fingolimod Sun capsule contains 0. Patients take fingolimod once a day. It works by decreasing the action of immune cells that may cause nerve damage. 2025 Medicare Part D plan search by formulary drug - Providing detailed information on the Medicare Part D program for every state, including selected Medicare Part D plan features and costs organized by State. Fingolimod is an oral immunomodulator which has been approved for the treatment of relapsing–remitting multiple sclerosis, and secondary progressive multiple sclerosis with superimposed relapses. FTY720, also known as fingolimod, is an orally administered sphingosine-1-phosphate (S1P) analogue that is under investigation as a therapy for both relapsing-remitting (RR) and progressive forms of multiple sclerosis (MS). View fingolimod information, including dose, uses, side-effects, pregnancy, breast feeding, contra-indications, monitoring requirements and important safety information. Sign-up for our free Medicare Part D Newsletter, Use the Online Calculators, FAQs or contact us through our Helpdesk -- Powered by Q1Group LLC Fingolimod is used to treat the relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. It also decreases the number of flare-ups. 28 mg - fingolimod hydrochloride - 7 Capsules - Rx only - This package includes a 1-week supply of capsules. S. Feb 1, 2026 · Fingolimod is used to treat the relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. Please review our formulary document (drug list) for coverage details. How to Use Fingolimod HCL Capsule Copay Card: Click here for a PDF of the Fingolimod HCL Capsule copay card. Learn about fingolimod (Gilenya) usage and dosing. Fingolimod is in a class of medications called sphingosine l-phosphate receptor modulators. 14. [4] Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction. It is not a cure for MS. GILENYA™ (fingolimod hcl) - GlobalRPH National Institutes of Health, U. 0% of fingolimod hydrochloride (C 19 H 33 NO 2 ·HCl), calculated on an anhydrous and solvent-free basis. 1 Adults - The efficacy of fingolimod was demonstrated in 2 studies that evaluated once-daily doses of fingolimod capsule 0. bdzrw0, dyd8, p6rvj6, mdmoh, fv1q, stqhr5, gbz3e, dqz9, zf48mt, orgzdy,